Access to anti-retroviral drugs, male in El Salvador
El Salvador: Access to anti-retroviral drugs, male was 78.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in El Salvador, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
El Salvador recorded 78.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
The figure is up 1.3% on the previous year and up 62.5% over ten years.
Over the whole period, access to anti-retroviral drugs, male in El Salvador peaked at 78.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places El Salvador 51st out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in El Salvador, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 1.0% | — |
| 2002 | 1.0% | +0.0% |
| 2003 | 3.0% | +200.0% |
| 2004 | 8.0% | +166.7% |
| 2005 | 13.0% | +62.5% |
| 2006 | 19.0% | +46.2% |
| 2007 | 23.0% | +21.1% |
| 2008 | 28.0% | +21.7% |
| 2009 | 35.0% | +25.0% |
| 2010 | 41.0% | +17.1% |
| 2011 | 43.0% | +4.9% |
| 2012 | 41.0% | -4.7% |
| 2013 | 46.0% | +12.2% |
| 2014 | 48.0% | +4.3% |
| 2015 | 52.0% | +8.3% |
| 2016 | 55.0% | +5.8% |
| 2017 | 56.0% | +1.8% |
| 2018 | 57.0% | +1.8% |
| 2019 | 68.0% | +19.3% |
| 2020 | 71.0% | +4.4% |
| 2021 | 75.0% | +5.6% |
| 2022 | 76.0% | +1.3% |
| 2023 | 77.0% | +1.3% |
| 2024 | 78.0% | +1.3% |
El Salvador compared with similar countries
- El Salvador's 78.0% is above the median for upper middle income countries, which is 65.0%, 1.2× the median. (39 countries reporting)
- El Salvador's 78.0% is above the median for Latin America & Caribbean, which is 67.0%, 1.2× the median. (23 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, male in El Salvador changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2003 | +200.0% | 1.0% | 3.0% |
| 2004 | +166.7% | 3.0% | 8.0% |
| 2005 | +62.5% | 8.0% | 13.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 13.1% | 0.0% | 35.0% | 10 |
| 2010s | 50.7% | 41.0% | 68.0% | 10 |
| 2020s | 75.4% | 71.0% | 78.0% | 5 |
Countries ranked near El Salvador
More gender data for El Salvador
- Child population (UN estimates and projections) 1,446 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.44 % change on previous year (2030)
- Population 5,040 (2030)
- Working-age population (UN estimates and projections) 5,040 (2030)
- Population (UN estimates and projections), annual growth rate 0.8586 % change on previous year (2030)
- Age population, age 00, female, interpolated 47,387 (2025)
- Age population, age 00, male, interpolated 49,616 (2025)
- Age population, age 01, female, interpolated 47,477 (2025)
- Age population, age 01, male, interpolated 49,704 (2025)
- Age population, age 02, female, interpolated 47,581 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in El Salvador?
- Access to anti-retroviral drugs, male in El Salvador was 78.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in El Salvador?
- The highest recorded value was 78.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in El Salvador?
- The lowest recorded value was 0.0% in 2000.
- How does El Salvador rank for access to anti-retroviral drugs, male?
- El Salvador ranks 51st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in El Salvador?
- Over the last ten years it is up 62.5%. The long-run trend across the full record is volatile.
- Where does this El Salvador data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.